Research Nester published a report titled “Hematopoietic Stem Cells Transplantation Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global hematopoietic stem cells transplantation market in terms of market segmentation by transplant type, disease type, application, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global hematopoietic stem cells transplantation market is anticipated to attain a CAGR of ~8% over the forecast period, i.e., 2022 – 2031. The market is segmented based on application, into bone marrow transplant (BMT), peripheral blood stem cells transplant (PBSCT), cord blood transplant (CBT) and others. Among these, the bone marrow transplant (BMT) segment is estimated to garner a notable revenue share over the forecast period, owing to the high success rate of bone marrow transplant, along with easier availability of bone marrow cells for transplant, as they can be retrieved from the patients itself, or their family members.
The global hematopoietic stem cells transplantation market is estimated to grow on the back of high prevalence of blood cancer, and other hematopoietic disorders, which require transplant or transfusion of hematopoietic stem cells. According to the data by World Health Organization (WHO), cancer is the second leading cause of death worldwide, accounting for 10 million deaths, in 2020. Moreover, the high success rate of stem cell transplant, along with the rising adoption of advanced treatment methods to treat chronic diseases, are anticipated to boost the market growth.
On the basis of geographical analysis, the global hematopoietic stem cells transplantation market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period, owing to the high prevalence of leukemia in the region. According to the data from National Cancer Institute, leukemia accounted for 3.2% of all new cancer cases, and 3.9% of all cancer deaths in the United States in 2020.
Access our detailed report at:
https://www.researchnester.com/reports/hematopoietic-stem-cells-transplantation-market/3937
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
High Prevalence of Blood Cancer to Boost the Market Growth
The growing cases of rare cancers, such as, leukemia, lymphoma, and multiple myeloma is anticipated to increase the demand for hematopoietic stem cells. These cells have the potency to generate new blood cells, and facilitate the process of hematopoiesis. This is estimated to primarily boost the market growth.
However, very high cost of stem cell transplant is expected to operate as key restraint to the growth of global hematopoietic stem cells transplantation market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global hematopoietic stem cells transplantation market which includes company profiling of Escape Therapeutics, Inc., Lonza Group Ltd., Regen BioPharma, Inc., ThermoGenesis Holdings, Inc., CSG-BIO Company, Inc. (CellSave), CBR Systems, Inc., Pluristem Inc., Global Cord Blood Corporation, ViaCord, LLC, and Cynata Therapeutics Limited. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global hematopoietic stem cells transplantation market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request Report Sample@
https://www.researchnester.com/sample-request-3937
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: [email protected]
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919